BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$592M |
| 2 |
GE Aerospace
GE
|
+$441M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$428M |
| 4 |
iShares Semiconductor ETF
SOXX
|
+$423M |
| 5 |
Meta Platforms (Facebook)
META
|
+$387M |
Top Sells
| 1 |
Amazon
AMZN
|
+$892M |
| 2 |
Alibaba
BABA
|
+$816M |
| 3 |
Advanced Micro Devices
AMD
|
+$567M |
| 4 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$494M |
| 5 |
IBM
IBM
|
+$477M |
Sector Composition
| 1 | Technology | 28.65% |
| 2 | Consumer Discretionary | 9.73% |
| 3 | Financials | 9.7% |
| 4 | Healthcare | 9.64% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IGMS
4001
DELISTED
IGM Biosciences
IGMS
| $3.51K | ﹤0.01% |
3,133
-9
| -0.3% | -$10 |
|
4002
Lifetime Brands
LCUT
$88.4M
| $3.45K | ﹤0.01% |
676
-1,862
| -73% | -$9.5K |
|
4003
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.3B
| $3.44K | ﹤0.01% |
29
| – | – |
|
4004
SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$8.12B
| $3.41K | ﹤0.01% |
113
-787
| -87% | -$23.8K |
|
4005
Seres Therapeutics
MCRB
$139M
| $3.39K | ﹤0.01% |
305
-2
| -0.7% | -$22 |
|
|
FLD
4006
Fold Holdings, Inc. Class A Common Stock
FLD
$154M
| $3.38K | ﹤0.01% |
+800
| New | +$3.38K |
|
4007
LiveOne
LVO
$66.3M
| $3.38K | ﹤0.01% |
4,476
-1,782
| -28% | -$1.35K |
|
4008
Value Line
VALU
$357M
| $3.37K | ﹤0.01% |
86
+31
| +56% | +$1.21K |
|
4009
DHI Group
DHX
$141M
| $3.34K | ﹤0.01% |
1,123
| – | – |
|
4010
Galectin Therapeutics
GALT
$344M
| $3.29K | ﹤0.01% |
1,559
| – | – |
|
4011
Lineage Cell Therapeutics
LCTX
$306M
| $3.27K | ﹤0.01% |
3,608
-5,971
| -62% | -$5.42K |
|
4012
SES AI
SES
$456M
| $3.26K | ﹤0.01% |
3,672
-6,141
| -63% | -$5.46K |
|
4013
QuickLogic
QUIK
$92.3M
| $3.23K | ﹤0.01% |
525
-391
| -43% | -$2.41K |
|
|
GPMT
4014
Granite Point Mortgage Trust
GPMT
$142M
| $3.23K | ﹤0.01% |
1,309
-1,862
| -59% | -$4.6K |
|
4015
Lyell Immunopharma
LYEL
$246M
| $3.12K | ﹤0.01% |
353
-7,960
| -96% | -$70.4K |
|
4016
First Trust Smith Unconstrained Bond ETF
UCON
$2.98B
| $3.06K | ﹤0.01% |
123
+103
| +515% | +$2.56K |
|
4017
Rekor Systems
REKR
$152M
| $3.03K | ﹤0.01% |
2,612
-4,847
| -65% | -$5.62K |
|
4018
American Realty Investors
ARL
$256M
| $3.02K | ﹤0.01% |
214
-2,018
| -90% | -$28.5K |
|
4019
SmartRent
SMRT
$273M
| $2.98K | ﹤0.01% |
3,012
-85,057
| -97% | -$84.2K |
|
4020
LanzaTech
LNZA
$45.1M
| $2.86K | ﹤0.01% |
105
+44
| +72% | +$1.2K |
|
|
ONL
4021
Orion Office REIT
ONL
$168M
| $2.85K | ﹤0.01% |
1,339
-2,338
| -64% | -$4.98K |
|
|
BNR
4022
Burning Rock Biotech
BNR
$89.4M
| $2.84K | ﹤0.01% |
900
+100
| +13% | +$316 |
|
4023
ADS-TEC Energy
ADSE
$556M
| $2.76K | ﹤0.01% |
+200
| New | +$2.76K |
|
4024
SPDR S&P 600 Small Cap Growth ETF
SLYG
$3.56B
| $2.75K | ﹤0.01% |
+31
| New | +$2.75K |
|
4025
Invivyd
IVVD
$299M
| $2.75K | ﹤0.01% |
3,846
-2,802
| -42% | -$2K |
|